1395346-28-7: Deferasirox Salicyloyl Ester

1395346-28-7: Deferasirox Salicyloyl Ester

Deferasirox Salicyloyl Ester Cas No. 1395346-28-7 with IUPAC Name 4-(3-(2-((2-hydroxybenzoyl)oxy)phenyl)-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl)benzoic acid is an impurity of Deferasirox which is mainly used to reduce chronic iron overload in patients receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. The first oral medication approved in the United States for this purpose is Deferasirox.

Additional information on CAS 1395346-28-7

Catalogue No.

VE008731
CAS No.

1395346-28-7
Molecular Formula

C28H19N3O6
Molecular Weight

493.5 g/mol
Parent drug

Deferasirox
IUPAC Name

4-(3-(2-((2-hydroxybenzoyl)oxy)phenyl)-5-(2-hydroxyphenyl)-1H-1, 2, 4-triazol-1-yl)benzoic acid
Synonyms

N/A
References

Choudhry, V. P., and Rahul Naithani. “Current Status of Iron Overload and Chelation with Deferasirox.” The Indian Journal of Pediatrics, vol. 74, no. 8, Aug. 2007, pp. 759–64, https://doi.org/10.1007/s12098-007-0134-7.
Status

In-stock

Other products related to deferasirox

Request a quote

1395346-28-7: Deferasirox Salicyloyl Ester

1395346-28-7: Deferasirox Salicyloyl Ester
Catalogue No.

VE008731
CAS No.

1395346-28-7
Molecular Formula

C28H19N3O6
Molecular Weight

493.5 g/mol
Parent drug

Deferasirox
IUPAC Name

4-(3-(2-((2-hydroxybenzoyl)oxy)phenyl)-5-(2-hydroxyphenyl)-1H-1, 2, 4-triazol-1-yl)benzoic acid
Synonyms

N/A
References

Choudhry, V. P., and Rahul Naithani. “Current Status of Iron Overload and Chelation with Deferasirox.” The Indian Journal of Pediatrics, vol. 74, no. 8, Aug. 2007, pp. 759–64, https://doi.org/10.1007/s12098-007-0134-7.
Status

In-stock
ListName

Deferasirox Salicyloyl Ester
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url